Metastatic Breast Cancer Global Clinical Trials Review, H1, 2012
Metastatic Breast Cancer Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “Metastatic Breast Cancer Global Clinical Trials Review, H1, 2012" provides data on the Metastatic Breast Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Breast Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metastatic Breast Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Summary
GlobalData's clinical trial report, “Metastatic Breast Cancer Global Clinical Trials Review, H1, 2012" provides data on the Metastatic Breast Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Breast Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metastatic Breast Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Contents
IntroductionMetastatic Breast Cancer
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Metastatic Breast Cancer
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Metastatic Breast Cancer Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
Novartis AG
Clinical Trial Overview of Novartis AG
Bristol-Myers Squibb Company
Clinical Trial Overview of Bristol-Myers Squibb Company
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
Amgen Inc.
Clinical Trial Overview of Amgen Inc.
Celgene Corporation
Clinical Trial Overview of Celgene Corporation
Sanofi
Clinical Trial Overview of Sanofi
Genentech, Inc.
Clinical Trial Overview of Genentech, Inc.
Taiho Pharmaceutical Co., Ltd.
Clinical Trial Overview of Taiho Pharmaceutical Co., Ltd.
Intas Pharmaceuticals Ltd.
Clinical Trial Overview of Intas Pharmaceuticals Ltd.
Eisai Inc.
Clinical Trial Overview of Eisai Inc.
Boehringer Ingelheim GmbH
Clinical Trial Overview of Boehringer Ingelheim GmbH
US Oncology, Inc.
Clinical Trial Overview of US Oncology, Inc.
ARCAGY - GINECO
Clinical Trial Overview of ARCAGY - GINECO
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
Johnson & Johnson
Clinical Trial Overview of Johnson & Johnson
Dr. Reddy's Laboratories Limited
Clinical Trial Overview of Dr. Reddy's Laboratories Limited
Clinical Trial Overview of Top Universities / Institutes / Hospitals
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Clinical Trial Overview of Dana-Farber Cancer Institute
Vanderbilt-Ingram Cancer Center
Clinical Trial Overview of Vanderbilt-Ingram Cancer Center
Sarah Cannon Research Institute
Clinical Trial Overview of Sarah Cannon Research Institute
University of Medicine and Dentistry New Jersey
Clinical Trial Overview of University of Medicine and Dentistry New Jersey
FUDAN University
Clinical Trial Overview of FUDAN University
Fred Hutchinson Cancer Research Center
Clinical Trial Overview of Fred Hutchinson Cancer Research Center
Southeastern Medical Oncology Center
Clinical Trial Overview of Southeastern Medical Oncology Center
Stanford University
Clinical Trial Overview of Stanford University
Sidney Kimmel Comprehensive Cancer Center
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center
Northwestern University
Clinical Trial Overview of Northwestern University
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
European Organization for Research and Treatment of Cancer
Clinical Trial Overview of European Organization for Research and Treatment of Cancer
Southwest Oncology Group
Clinical Trial Overview of Southwest Oncology Group
Duke University
Clinical Trial Overview of Duke University
Washington University School of Medicine
Clinical Trial Overview of Washington University School of Medicine
Albert Einstein College of Medicine of Yeshiva University
Clinical Trial Overview of Albert Einstein College of Medicine of Yeshiva University
University of Michigan Comprehensive Cancer Center
Clinical Trial Overview of University of Michigan Comprehensive Cancer Center
New York University School of Medicine
Clinical Trial Overview of New York University School of Medicine
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source
LIST OF TABLES
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012*
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials, BRIC Countries, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials, G7 Countries, 2012*
Metastatic Breast Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials, E7 Countries, 2012*
Metastatic Breast Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012*
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Metastatic Breast Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2012*
Metastatic Breast Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2012*
Metastatic Breast Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Genentech, Inc., 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Taiho Pharmaceutical Co., Ltd., 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Intas Pharmaceuticals Ltd., 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by US Oncology, Inc., 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ARCAGY - GINECO, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Reddy's Laboratories Limited, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt-Ingram Cancer Center, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarah Cannon Research Institute, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Medicine and Dentistry New Jersey, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southeastern Medical Oncology Center, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Albert Einstein College of Medicine of Yeshiva University, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan Comprehensive Cancer Center, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2012*
LIST OF FIGURES
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012*
Metastatic Breast Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials, E7 Countries (%), 2012*
Metastatic Breast Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
GlobalData Methodology Skip to top